ID: MRFR/MED/4716-HCR | February 2021 | Region: Global | 100 pages
The small animal imaging market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the small animal imaging market is expected to grow at a CAGR ~ 6.5 % during the forecast period of 2018–2023.
Small animal imaging is a process employed using imaging devices and reagents for monitoring the molecular or cellular process for biochemical, biological, diagnostic or therapeutic application in animals such as rats and mice for drug development and gene expression studies. Moreover, the small imaging systems are the cost-effective method for regular validation and commercialization of new drugs as it includes the whole body scan of the animals.
The market growth is driven by the increasing demand for non-invasive small animal imaging techniques and technological advancements in the field of small animal imaging techniques. Furthermore, prominent market players are focused on continuous launches of product which is likely to contribute to the market growth. For instance, in September 2016, Aspect Imaging introduced M-series of compact MR imaging systems for pre-clinical research along with new integrated simultaneous PET-MRI systems.
However, stringent government regulations regarding animal usage in experiments and the high cost of devices may restrain the growth of small animal imaging market.
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VP, CEO's, Marketing Director, Business Development Manager and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the small animal imaging market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.
The small animal imaging market is segmented on the basis of the modality and reagents.
On the basis of the modality, the market is classified into optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, photoacoustic imaging systems, and Magnetic Particle Imaging (MPI) systems. The optical imaging systems are further segmented into bioluminescence/ fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-Ray/optical + CT systems. The nuclear imaging systems are segmented into micro-Pet systems, micro-spect systems, and trimodality (spect/pet/CT) systems. The micro-pet system is further segmented into standalone pet systems, pet/CT system, and pet/MRI systems. The micro-spect system is further segmented into standalone spect systems, spect/CT system, and spect/MRI systems.
On the basis of reagent, the market is segmented as optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents are further segmented as bioluminescent imaging reagents and fluorescent imaging reagents. The bioluminescent imaging reagents are further segmented into luciferins, pro-luciferins, coelenterazine, and other bioluminescent imaging reagents. The fluorescent imaging reagents are further segmented as green fluorescent proteins, red fluorescent proteins, infrared dyes, other fluorescent imaging reagents. The nuclear imaging reagents are segmented into pet tracers and spect probes. The pet tracers are further classified into fluorine-18-based small animal pet tracers, carbon-11-based small animal pet tracers, copper-64-based small animal pet tracers, and other spect probes.
The spect probes are further segmented into technetium-99m-based small animal spect probes, iodine-131-based small animal spect probes, gallium-67-based small animal spect probes, thallium-201-based small animal spect probes, and other spect probes. The MRI contrast agents are segmented into gadolinium-based small animal contrast agents, iron-based small animal contrast agents, and manganese-based small animal contrast agents. The CT contrast agents are further segmented into iodine-based small animal CT contrast agents, barium-based small animal CT contrast agents, gold nanoparticles and gastrografin-based small animal CT contrast media.
Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The Americas small animal imaging market is further segmented into North America, and South America. North America is further classified as U.S. and Canada.
The Europe small animal imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and the Rest of Western Europe.
The Asia Pacific small animal imaging market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.
The Middle East & Africa small animal imaging market is segmented into the Middle East and Africa.
Regional Market Summary
Global Small Animal Imaging Market, by Region Market Share, 2017 (%)
Source: MRFR Analysis
The Americas is likely to dominate the global small animal imaging market owing to investments by clinical research organizations in pre-clinical studies, increasing government funding in research activities and increasing number of pharmaceutical and research-based organizations. For instance, the National Institute of Health (NIH) received 1 Billion USD, in the year 2015 for life science and health-related research and development programs. Moreover, the presence of leading market players such as PerkinElmer Inc., Bruker Corporation, Trifoil Imaging, and LI-COR Biosciences within the region contributes to the market growth.
Europe is expected to hold the second position in the global small animal imaging market. The market growth is attributed to rising R&D investments by pharmaceutical companies and growing number of research organizations for diagnosis of diseases. For instance, the European Commission stated that the R&D spending by pharmaceuticals and biotechnology sector grew by 8.7% in 2014.
The Asia Pacific is the fastest growing region in global small animal imaging market. The developing countries such as China and India are offering high growth opportunities for the small animal imaging market players. Moreover, increasing government support for biotechnology and pharmaceutical R&D and growing number of translational research activities contributes to the market growth.
The Middle East & Africa holds the lowest share of the global small animal imaging market due to low development in the healthcare sector, lack of technical knowledge, and poor medical facilities.
Some of the key players in the global small animal imaging market are PerkinElmer Inc. (U.S.) Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany).
Small Animal Imaging Market, by Modality
Small Animal Imaging Market, by Reagents
Small Animal Imaging Market, by Region
|Market Size||2027: Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Modality and Reagents|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||PerkinElmer Inc. (U.S.) Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany).|
|Key Market Opportunities||Prominent market players are focused on continuous launches of product|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The small animal imaging market would find a CAGR of 6.5% during the forecast period of 2018 to 2023.
Strict regulations about the use of animals and costly devices can hold back the small animal imaging market growth.
The American small animal imaging market would be the dominating one.
The Asia Pacific would be the fastest-growing region in the small animal imaging market.
Factors, such as and technological advancements and non-invasive small animal imaging techniques, would ensure high growth for the small animal imaging market.